American Oncology Network, INC Form 4 insider transactions

William Valle, a director at American Oncology Network, Inc., received a grant of 5,000 shares of Class A Common Stock.

Bradley M. Fluegel, a director of American Oncology Network, Inc., acquired 5,000 shares of Class A Common Stock on July 16, 2024, as part of his compensation for serving on the Board of Directors.

Stephen Divers, Chief Medical Officer of American Oncology Network, receives 36,000 shares of Class A Common Stock as part of his compensation.

Erica Mallon, General Counsel of American Oncology Network, Inc., was granted 36,000 shares of Class A Common Stock for her service to the company.

David Afshar, CFO of American Oncology Network, receives 150,000 shares of Class A Common Stock, vesting over time and performance.

Todd Schonherz, CEO of American Oncology Network, Inc., reports the acquisition of 300,000 shares of Class A Common Stock on July 16, 2024, as part of his compensation.

Stephen Divers, Chief Medical Officer and Director at American Oncology Network, purchased 5,000 shares of Class A Common Stock at $2.15 per share on May 24, 2024.

Todd Schonherz, CEO of American Oncology Network, recently purchased shares of the company's Class A Common Stock.

Bradley M. Fluegel, a director of American Oncology Network, Inc., acquired 14,981 shares of Class A Common Stock on May 4, 2024, as compensation for his service on the board.

Director William Valle received 14,981 shares of Class A Common Stock from American Oncology Network, Inc. for his service on the Board of Directors.

Stephen Divers, Chief Medical Officer and Director at American Oncology Network, sold shares to cover tax obligations related to vesting stock.

Stephen Divers, Chief Medical Officer and Director at American Oncology Network, acquired 59,500 shares of Class A Common Stock on March 19, 2024.